Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
ChemoCentryx revenue
ChemoCentryx's revenue is $32.2 million.
What is ChemoCentryx's revenue?
- ChemoCentryx's revenue growth from 2011 to 2021 is 1.74%.
- ChemoCentryx has 76 employees, and the revenue per employee ratio is $424,000.
- ChemoCentryx's peak quarterly revenue was $56.3M in 2017(q4).
- ChemoCentryx peak revenue was $82.5M in 2017.
- ChemoCentryx annual revenue for 2020 was 64.9M, 79.61% growth from 2019.
- ChemoCentryx annual revenue for 2021 was 32.2M, -50.34% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
ChemoCentryx historical revenue
ChemoCentryx's peak revenue was $82.5M in 2017. The peak quarterly revenue was $56.3M in 2017(q4).
ChemoCentryx's revenue increased from $31.7m in 2011 to $32.2M currently. That's a 1.74% change in annual revenue.
ChemoCentryx annual revenue
ChemoCentryx annual revenue over time
| Fiscal year / year | ChemoCentryx revenue |
|---|---|
| 2011 | $31.7M |
| 2012 | $5.4M |
| 2013 | $6.1M |
| 2016 | $11.9M |
| 2017 | $82.5M |
| 2018 | $42.9M |
| 2019 | $36.1M |
| 2020 | $64.9M |
| 2021 | $32.2M |
How accurately did ChemoCentryx's revenue projections match actual performance?
ChemoCentryx annual growth
ChemoCentryx saw the greatest revenue growth in 2017, when revenue increased by 591.22%.
ChemoCentryx had the lowest revenue growth in 2012, when revenue changed by -82.89%.
ChemoCentryx annual growth rate over time
| Year | ChemoCentryx growth |
|---|---|
| 2012 | -83%↓ |
| 2013 | 12%↑ |
| 2016 | 97%↑ |
| 2017 | 591%↑ |
| 2018 | -48%↓ |
| 2019 | -16%↓ |
| 2020 | 80%↑ |
| 2021 | -50%↓ |
ChemoCentryx quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
ChemoCentryx quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2011 | - | - | - | $26.1M |
| 2012 | $1.0M | $1.1M | $1.1M | $2.1M |
| 2013 | $1.9M | $1.9M | $1.5M | $725,000 |
| 2016 | - | $2.8M | $4.3M | $4.9M |
| 2017 | $8.2M | $8.9M | $9.0M | $56.3M |
| 2018 | $9.5M | $15.0M | $9.0M | $9.3M |
| 2019 | $8.3M | $7.2M | $10.6M | $10.0M |
| 2020 | $6.0M | $49.4M | $5.1M | $4.4M |
| 2021 | $10.4M | $1.8M | $17.7M | $2.3M |
| 2022 | $5.5M | $11.8M | - | - |
ChemoCentryx jobs nearby
Do you work at ChemoCentryx?
Did ChemoCentryx meet its revenue projections?
ChemoCentryx financial information
| CEO | Thomas J. Schall |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 76 |
| Date Founded | 1997 |
| Headquarters | Mountain View, California |
| Number of Locations | 2 |
| Revenue | $32.2M |
| Net Income | -$131,755,000 |
| Gross Proft | $31.9M (2021) |
| PE Ratio | -4.20 |
| Market Capitalization | $552.8M |
| Total Assets | $425,652,000 |
| Ticker | CCXI |
ChemoCentryx jobs you might like
ChemoCentryx financing
ChemoCentryx received early financing of $14.0M on 2003-10-13.
| Series | Round size | Date |
|---|---|---|
| Grant | $14M | 10/2003 |
| Series B | $33M | 06/2004 |
| Series C | $17.7M | 08/2006 |
| Series D | $29.8M | 03/2007 |
| Series E | $50M | 10/2008 |
| Post Ipo Equity | $64.4M | 04/2013 |
| Post Ipo Debt | $100M | 01/2020 |
| Post Ipo Equity | $325.4M | 06/2020 |
ChemoCentryx investors
| Investors | Security type |
|---|---|
| HBM Healthcare Investments AG | Series B |
| HealthCap | Series B |
| Gimv | Series B |
| Alta Partners | Series B |
| OrbiMed Advisors | Series B |
| HBM Healthcare Investments AG | Series C |
| Jennison Associates | Series C |
| Gimv | Series C |
| Alta Partners | Series C |
| OrbiMed Advisors | Series C |
| BIO TECHNE CORP | Series C |
| HBM Healthcare Investments AG | Series D |
| GLAXO GROUP LIMITED | Series D |
| Gimv | Series D |
| Alta Partners | Series D |
| OrbiMed Advisors | Series D |
| HBM Healthcare Investments AG | Series E |
| GLAXO GROUP LIMITED | Series E |
| HealthCap | Series E |
| Alta Partners | Series E |
| HERCULES CAPITAL INC | Post Ipo Debt |
Search for jobs
ChemoCentryx highest paying jobs
Zippia gives an in-depth look into the details of ChemoCentryx, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ChemoCentryx. The employee data is based on information from people who have self-reported their past or current employments at ChemoCentryx. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ChemoCentryx. The data presented on this page does not represent the view of ChemoCentryx and its employees or that of Zippia.
ChemoCentryx may also be known as or be related to CHEMOCENTRYX INC., ChemoCentryx, ChemoCentryx Inc, ChemoCentryx, Inc., Chemocentryx and Chemocentryx, Inc.